Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 16/20 | 0.38 |
| ▸ | MAPK11 | Q15759 | 4/20 | 0.38 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.35 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.35 |
| ▸ | HTR5A | P47898 | 1/20 | 0.33 |
| ▸ | KIT | P10721 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | PI4KA | P42356 | 1/20 | 0.32 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.32 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.32 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3154098 | 0.89 | HTR7 (0.34) | MAPK14MAPK11PI4KAPI4K2BPI4K2A | |
| SCHEMBL3148991 | 0.75 | MAPK14 (0.49) | MAPK14KIT | |
| SCHEMBL3154106 | 0.73 | MAPK14 (0.49) | MAPK14MAPK11 | |
| SCHEMBL3146065 | 0.72 | MAPK14 (0.48) | MAPK14MAPK11MAPK13MAPK12KIT | |
| SCHEMBL3149695 | 0.72 | MAPK14 (0.41) | MAPK14 | |
| SCHEMBL3149778 | 0.71 | MAPK14 (0.48) | MAPK14 | |
| SCHEMBL3145569 | 0.70 | MAPK14 (0.50) | MAPK14KIT | |
| SCHEMBL3145748 | 0.69 | MAPK14 (0.48) | MAPK14MAPK11 | |
| SCHEMBL3148658 | 0.69 | MAPK14 (0.48) | MAPK14KIT | |
| SCHEMBL3144145 | 0.68 | MAPK14 (0.53) | MAPK14MAPK11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1699800-B1 | BICYCLIC HETEROCYCLIC P-38 KINASE INHIBITORS | NOVARTIS AG (CH) | 2010-02-10 | — | — | EP | claimed |